United States · FDA National Drug Code directory
Ezetimibe
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-226_5009c162-91bb-425a-a688-6237c259d33e
- Product NDC
- 68462-226
- Form
- TABLET
- Composition / generic term
- Ezetimibe
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220429 / 20270101
Source-listed ingredients
- EZETIMIBE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (68462-226-05) · 68462-226-05
- 1000 TABLET in 1 BOTTLE (68462-226-10) · 68462-226-10
- 10 BLISTER PACK in 1 CARTON (68462-226-11) / 10 TABLET in 1 BLISTER PACK · 68462-226-11
- 30 TABLET in 1 BOTTLE (68462-226-30) · 68462-226-30
- 90 TABLET in 1 BOTTLE (68462-226-90) · 68462-226-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →